Purpose Nowadays, the efficacy of teriparatide in treating osteoporosis was widely
accepted, but the discussion about using teriparatide to enhance fracture healing hasn't …

Background Bone tissue engineering and the research surrounding peptides has expanded
significantly over the last few decades. Several peptides have been shown to support and …

Background There is a medical need for therapies that improve hip fracture healing.
Teriparatide (Forteo®/Forsteo®, recombinant human parathyroid hormone) is a bone …

Background Bisphosphonates (BPs) are the most commonly used anti-osteoporotic drugs,
which have been proven to reduce the risk of osteoporotic fractures. However, use of BPs …

Objectives: Human parathyroid hormone (PTH) is known to be efficacious in the treatment of
osteoporosis and reduction of risk of vertebral and nonvertebral fractures; however, its role …

Objective The aim of the study was to evaluate the efficacy and safety of teriparatide
compared to other treatments for postmenopausal osteoporosis. Methods A review of …

Articular cartilage is characterized by a poor self-healing capacity due to its aneural and
avascular nature. Once injured, it undergoes a series of catabolic processes which lead to …

Osteoporotic intertrochanteric fractures result in serious health problems and decrease
health-related quality of life (HRQoL). Faster time-to-union is important for early return to …

Purpose. This meta‐analysis is to assess the effectiveness of teriparatide in fracture healing
and clinical function improvement of the osteoporotic patients. Methods. We searched …

Background: Osteoporosis drugs might affect fracture-healing. We therefore studied the
effects of teriparatide in comparison with risedronate on recovery after pertrochanteric hip …